Myelokathexis treated with recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF)

Br J Haematol. 1992 Feb;80(2):254-6. doi: 10.1111/j.1365-2141.1992.tb08910.x.

Authors

U Hess¹, A Ganser, H G Schnürch, G Seipelt, O G Ottmann, S Falk, G Schulz, D Hoelzer

Affiliation

¹ Department of Haematology, University of Frankfurt, Germany.

PMID: 1550786
DOI: 10.1111/j.1365-2141.1992.tb08910.x

No abstract available

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Female
Granulocyte-Macrophage Colony-Stimulating Factor / adverse effects
Granulocyte-Macrophage Colony-Stimulating Factor / therapeutic use*
Humans
Leukocyte Count / drug effects
Neutropenia / drug therapy*
Primary Myelofibrosis / chemically induced
Recombinant Proteins / adverse effects
Recombinant Proteins / therapeutic use

Substances

Recombinant Proteins
Granulocyte-Macrophage Colony-Stimulating Factor